Medical diagnostics company Know Labs Inc (OTCQB: KNWN) on Wednesday confirmed the efficacy of a light bulb in inactivating multiple variants of SARS-CoV-2, the virus that causes COVID-19, based on Texas Biomedical Research Institute's new independent test data.

The light bulb is reportedly produced by the company's wholly owned subsidiary Particle Inc.

Earlier in 2021, Know Labs confirmed that Particle bulbs were effective against the Washington SARS-CoV-2 strain.

Additionally, the multiple tests performed by Texas Biomed demonstrated a 95% reduction in the SARS-CoV-2 virus after five hours of exposure to the Particle bulb, a 99% reduction in six hours and 99.9% reduction in 8 hours.

Texas Biomed's additional tests confirmed that Particle bulbs were equally efficient against the Alpha and Delta variants.

In conjunction, Know Labs Inc has received product and packaging samples from its contract manufacturer in Asia, a final step before commercial production can begin. It is exploring potential strategic and channel partner opportunities.